A detailed history of Altus Wealth Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Altus Wealth Group LLC holds 4,439 shares of NVS stock, worth $503,604. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,439
Holding current value
$503,604
% of portfolio
0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

BUY
$97.14 - $115.57 $431,204 - $513,015
4,439 New
4,439 $494,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $6,429 - $7,582
-77 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $6,011 - $7,271
77 New
77 $8,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $244B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Altus Wealth Group LLC Portfolio

Follow Altus Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altus Wealth Group LLC with notifications on news.